Perception of castration value over cost in the metastatic prostate cancer scenario: a contemporary pharmacoeconomic perspective
Int Braz J Urol
.
2022 Jan-Feb;48(1):175-179.
doi: 10.1590/S1677-5538.IBJU.2021.0258.
Authors
Luciana Saboya Brito Dal Col
1
2
,
Danilo L Andrade
1
,
Lucas M Gon
1
,
Diego M Capibaribe
1
,
Marcelo P Amaro
1
2
,
Natássia C C Truzzi
1
,
Barbara R Malkomes
1
2
,
Leonardo O Reis
1
2
Affiliations
1
UroScience, Universidade Estadual de Campinas - UNICAMP, Campinas, SP, Brasil.
2
Departamento de Urologia, Pontifícia Universidade Católica de Campinas - PUC - Campinas, Campinas, SP, Brasil.
PMID:
34115454
PMCID:
PMC8691248
DOI:
10.1590/S1677-5538.IBJU.2021.0258
No abstract available
Publication types
Editorial
MeSH terms
Economics, Pharmaceutical
Humans
Male
Neoplasm Metastasis
Orchiectomy
Perception
Prostatic Neoplasms* / surgery
Prostatic Neoplasms, Castration-Resistant* / drug therapy